These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17317742)

  • 21. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells.
    Chuang SY; Yang SH; Chen TY; Pang JH
    Eur J Pharmacol; 2011 Nov; 670(2-3):419-26. PubMed ID: 21925496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
    Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
    J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metalloproteinases and their tissue inhibitors in multiple sclerosis.
    Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H
    J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific.
    Förster C; Waschke J; Burek M; Leers J; Drenckhahn D
    J Physiol; 2006 Jun; 573(Pt 2):413-25. PubMed ID: 16543270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells.
    Shastry S; Tyagi SC
    J Cell Biochem; 2004 Sep; 93(1):207-13. PubMed ID: 15352177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
    Zechel J; Gohil H; Lust WD; Cohen A
    J Neurosci Res; 2002 Sep; 69(5):662-8. PubMed ID: 12210832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.
    Aoudjit F; Potworowski EF; St-Pierre Y
    J Immunol; 1998 Mar; 160(6):2967-73. PubMed ID: 9510201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.
    Taraboletti G; Sonzogni L; Vergani V; Hosseini G; Ceruti R; Ghilardi C; Bastone A; Toschi E; Borsotti P; Scanziani E; Giavazzi R; Pepper MS; Stetler-Stevenson WG; Bani MR
    Exp Cell Res; 2000 Aug; 258(2):384-94. PubMed ID: 10896789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
    Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
    J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells.
    Hakki SS; Hakki EE; Nohutcu RM
    J Periodontal Res; 2009 Dec; 44(6):794-802. PubMed ID: 19602122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2.
    Fujimura M; Watanabe M; Shimizu H; Tominaga T
    Acta Neurochir (Wien); 2007 Feb; 149(2):179-83; discussion 183. PubMed ID: 17043747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.